Disaster and mass casualty events in the pediatric population

Rita V Burke1, Ellen Iverson, Catherine J Goodhue

  • 1Department of Pediatric Surgery, Childrens Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA 90027, USA.

Insights

Pediatric disaster preparedness is crucial, as current plans often neglect children

Area of Science:

  • Disaster medicine
  • Pediatric emergency care
  • Public health preparedness

Background:

  • Recent disasters underscore the critical need for specialized pediatric disaster preparedness.
  • Children, comprising 25% of the U.S. population, have unique needs often overlooked in disaster planning.
  • Existing disaster plans are frequently inadequate due to the neglect of pediatric requirements.

Purpose of the Study:

  • To emphasize the importance of effective pediatric disaster management systems.
  • To identify key components for improving hospital and community-based disaster response for children.
  • To advocate for enhanced preparedness strategies addressing pediatric victims.

Main Methods:

  • Analysis of current disaster planning gaps concerning pediatric populations.
  • Identification of essential elements for robust pediatric disaster management systems.
  • Review of strategies for improving staff training, family reunification, and tool utilization.

Main Results:

  • Significant deficiencies exist in pediatric disaster preparedness nationwide.
  • Administrative and hospital leadership are pivotal in establishing effective systems.
  • Key interventions include staff training, family reunification protocols, and the use of specialized tools.

Conclusions:

  • Effective pediatric disaster management requires strong leadership commitment.
  • Improving preparedness necessitates a focus on training, reunification, and resource utilization.
  • Addressing overlooked pediatric needs is essential for comprehensive disaster response.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...